|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2005-9-30
|
|
pubmed:abstractText |
Although percutaneous transluminal angioplasty (PTA) is being widely used for the treatment of stenosis of peripheral arteries, the high in-stent restenosis rate (50-60%) in the femoropopliteal artery still remains an unsolved issue. Cilostazol is a unique antiplatelet drug that has vasodilatory effects and inhibits smooth muscle cell proliferation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1346-9843
|
|
pubmed:author |
pubmed-author:AwataMasakiM,
pubmed-author:IidaOsamuO,
pubmed-author:ItoNoriakiN,
pubmed-author:KitakazeMasafumiM,
pubmed-author:KotaniJun-IchiJ,
pubmed-author:MinamiguchiHitoshiH,
pubmed-author:MorozumiTakakazuT,
pubmed-author:NagataSeikiS,
pubmed-author:NantoShinsukeS,
pubmed-author:OnishiToshinariT,
pubmed-author:OshimaFusakoF,
pubmed-author:UematsuMasaakiM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
69
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1256-9
|
|
pubmed:meshHeading |
pubmed-meshheading:16195627-Aged,
pubmed-meshheading:16195627-Angioplasty, Balloon,
pubmed-meshheading:16195627-Cell Proliferation,
pubmed-meshheading:16195627-Female,
pubmed-meshheading:16195627-Femoral Artery,
pubmed-meshheading:16195627-Graft Occlusion, Vascular,
pubmed-meshheading:16195627-Humans,
pubmed-meshheading:16195627-Male,
pubmed-meshheading:16195627-Myocytes, Smooth Muscle,
pubmed-meshheading:16195627-Platelet Aggregation Inhibitors,
pubmed-meshheading:16195627-Stents,
pubmed-meshheading:16195627-Tetrazoles
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Cilostazol reduces target lesion revascularization after percutaneous transluminal angioplasty in the femoropopliteal artery.
|
|
pubmed:affiliation |
Kansai Rosai Hospital, Amagasaki, Japan. osa-iida@nifty.com
|
|
pubmed:publicationType |
Journal Article
|
